APP and Alzheimer disease: The discovery that certain early-onset familial forms of AD are caused by mutations in the transmembrane amyloid precursor protein (APP) that lead to enhanced production of Aβ peptides strongly suggested that amyloidogenic Aβ is intimately involved in the AD pathogenic process1.